2.High-throughput screening identifies established drugs as SARS-CoV-2 PLpro inhibitors.
Yao ZHAO ; Xiaoyu DU ; Yinkai DUAN ; Xiaoyan PAN ; Yifang SUN ; Tian YOU ; Lin HAN ; Zhenming JIN ; Weijuan SHANG ; Jing YU ; Hangtian GUO ; Qianying LIU ; Yan WU ; Chao PENG ; Jun WANG ; Chenghao ZHU ; Xiuna YANG ; Kailin YANG ; Ying LEI ; Luke W GUDDAT ; Wenqing XU ; Gengfu XIAO ; Lei SUN ; Leike ZHANG ; Zihe RAO ; Haitao YANG
Protein & Cell 2021;12(11):877-888
A new coronavirus (SARS-CoV-2) has been identified as the etiologic agent for the COVID-19 outbreak. Currently, effective treatment options remain very limited for this disease; therefore, there is an urgent need to identify new anti-COVID-19 agents. In this study, we screened over 6,000 compounds that included approved drugs, drug candidates in clinical trials, and pharmacologically active compounds to identify leads that target the SARS-CoV-2 papain-like protease (PLpro). Together with main protease (M
Antiviral Agents/therapeutic use*
;
Binding Sites
;
COVID-19/virology*
;
Coronavirus Papain-Like Proteases/metabolism*
;
Crystallography, X-Ray
;
Drug Evaluation, Preclinical
;
Drug Repositioning
;
High-Throughput Screening Assays/methods*
;
Humans
;
Imidazoles/therapeutic use*
;
Inhibitory Concentration 50
;
Molecular Dynamics Simulation
;
Mutagenesis, Site-Directed
;
Naphthoquinones/therapeutic use*
;
Protease Inhibitors/therapeutic use*
;
Protein Structure, Tertiary
;
Recombinant Proteins/isolation & purification*
;
SARS-CoV-2/isolation & purification*
3.Crystal structure of the African swine fever virus structural protein p35 reveals its role for core shell assembly.
Guobang LI ; Dan FU ; Guangshun ZHANG ; Dongming ZHAO ; Mingyu LI ; Xue GENG ; Dongdong SUN ; Yuhui WANG ; Cheng CHEN ; Peng JIAO ; Lin CAO ; Yu GUO ; Zihe RAO
Protein & Cell 2020;11(8):600-605
5. Cognitive behavior intervention-mediated rehabilitation in patients with degenerative lumbar surgery: a systematic evaluation
Zihe GUO ; Jingjing LIU ; Zhengxiang CHEN ; Wei LU
Chinese Journal of Practical Nursing 2019;35(21):1672-1678
Objective:
To systematically evaluate the effects of the implementation of the cognitive behavior intervention program on the rehabilitation of patients with degenerative lumbar spine surgery.
Methods:
6 Chinese-English databases, The Cochrane library, PubMed, EMBASE, Medline, CNKI, Wanfang, were used for the randomized controlled trial of cognitive behavioral intervention in patients undergoing degenerative lumbar surgery. Two researchers independently retrieved and extracted data and conducted meta-analysis using RevMan5.3 software.
Results:
The meta analysis results of 7 literatures showed that the Oswestry dysfunction index questionnaire [
6.The binding of a monoclonal antibody to the apical region of SCARB2 blocks EV71 infection.
Xuyuan ZHANG ; Pan YANG ; Nan WANG ; Jialong ZHANG ; Jingyun LI ; Hao GUO ; Xiangyun YIN ; Zihe RAO ; Xiangxi WANG ; Liguo ZHANG
Protein & Cell 2017;8(8):590-600
Entero virus 71 (EV71) causes hand, foot, and mouth disease (HFMD) and occasionally leads to severe neurological complications and even death. Scavenger receptor class B member 2 (SCARB2) is a functional receptor for EV71, that mediates viral attachment, internalization, and uncoating. However, the exact binding site of EV71 on SCARB2 is unknown. In this study, we generated a monoclonal antibody (mAb) that binds to human but not mouse SCARB2. It is named JL2, and it can effectively inhibit EV71 infection of target cells. Using a set of chimeras of human and mouse SCARB2, we identified that the region containing residues 77-113 of human SCARB2 contributes significantly to JL2 binding. The structure of the SCARB2-JL2 complex revealed that JL2 binds to the apical region of SCARB2 involving α-helices 2, 5, and 14. Our results provide new insights into the potential binding sites for EV71 on SCARB2 and the molecular mechanism of EV71 entry.
Amino Acid Sequence
;
Animals
;
Antibodies, Monoclonal
;
chemistry
;
genetics
;
metabolism
;
Binding Sites
;
Cell Line
;
Crystallography, X-Ray
;
Enterovirus A, Human
;
drug effects
;
genetics
;
growth & development
;
immunology
;
Fibroblasts
;
drug effects
;
virology
;
Gene Expression
;
HEK293 Cells
;
Humans
;
Immunoglobulin Fab Fragments
;
chemistry
;
genetics
;
metabolism
;
Lysosome-Associated Membrane Glycoproteins
;
chemistry
;
genetics
;
immunology
;
Mice
;
Models, Molecular
;
Protein Binding
;
Protein Conformation, alpha-Helical
;
Protein Conformation, beta-Strand
;
Protein Interaction Domains and Motifs
;
Receptors, Scavenger
;
chemistry
;
genetics
;
immunology
;
Receptors, Virus
;
chemistry
;
genetics
;
immunology
;
Recombinant Fusion Proteins
;
chemistry
;
genetics
;
immunology
;
Sequence Alignment
;
Sequence Homology, Amino Acid
;
Sf9 Cells
;
Spodoptera
;
Thermodynamics
7.Insight into the Ebola virus nucleocapsid assembly mechanism: crystal structure of Ebola virus nucleoprotein core domain at 1.8 Å resolution.
Shishang DONG ; Peng YANG ; Guobang LI ; Baocheng LIU ; Wenming WANG ; Xiang LIU ; Boran XIA ; Cheng YANG ; Zhiyong LOU ; Yu GUO ; Zihe RAO
Protein & Cell 2015;6(5):351-362
Ebola virus (EBOV) is a key member of Filoviridae family and causes severe human infectious diseases with high morbidity and mortality. As a typical negative-sense single-stranded RNA (-ssRNA) viruses, EBOV possess a nucleocapsid protein (NP) to facilitate genomic RNA encapsidation to form viral ribonucleoprotein complex (RNP) together with genome RNA and polymerase, which plays the most essential role in virus proliferation cycle. However, the mechanism of EBOV RNP formation remains unclear. In this work, we solved the high resolution structure of core domain of EBOV NP. The polypeptide of EBOV NP core domain (NP(core)) possesses an N-lobe and C-lobe to clamp a RNA binding groove, presenting similarities with the structures of the other reported viral NPs encoded by the members from Mononegavirales order. Most strikingly, a hydrophobic pocket at the surface of the C-lobe is occupied by an α-helix of EBOV NP(core) itself, which is highly conserved among filoviridae family. Combined with other biochemical and biophysical evidences, our results provides great potential for understanding the mechanism underlying EBOV RNP formation via the mobility of EBOV NP element and enables the development of antiviral therapies targeting EBOV RNP formation.
Crystallography, X-Ray
;
Ebolavirus
;
physiology
;
Humans
;
Nucleoproteins
;
chemistry
;
genetics
;
metabolism
;
Protein Structure, Tertiary
;
Structure-Activity Relationship
;
Virus Assembly
;
physiology
8.The newly emerged SARS-like coronavirus HCoV-EMC also has an "Achilles' heel": current effective inhibitor targeting a 3C-like protease.
Zhilin REN ; Liming YAN ; Ning ZHANG ; Yu GUO ; Cheng YANG ; Zhiyong LOU ; Zihe RAO
Protein & Cell 2013;4(4):248-250
Binding Sites
;
Cysteine Endopeptidases
;
metabolism
;
Humans
;
Isoxazoles
;
chemistry
;
pharmacology
;
Protease Inhibitors
;
chemistry
;
metabolism
;
pharmacology
;
Protein Structure, Tertiary
;
Pyrrolidinones
;
chemistry
;
pharmacology
;
Rhinovirus
;
drug effects
;
SARS Virus
;
drug effects
;
enzymology
;
Severe Acute Respiratory Syndrome
;
virology
;
Viral Proteins
;
antagonists & inhibitors
;
metabolism
9.A structural view of the antibiotic degradation enzyme NDM-1 from a superbug.
Yu GUO ; Jing WANG ; Guojun NIU ; Wenqing SHUI ; Yuna SUN ; Honggang ZHOU ; Yaozhou ZHANG ; Cheng YANG ; Zhiyong LOU ; Zihe RAO
Protein & Cell 2011;2(5):384-394
Gram-negative Enterobacteriaceae with resistance to carbapenem conferred by New Delhi metallo-β-lactamase 1 (NDM-1) are a type of newly discovered antibioticresistant bacteria. The rapid pandemic spread of NDM-1 bacteria worldwide (spreading to India, Pakistan, Europe, America, and Chinese Taiwan) in less than 2 months characterizes these microbes as a potentially major global health problem. The drug resistance of NDM-1 bacteria is largely due to plasmids containing the blaNDM-1 gene shuttling through bacterial populations. The NDM-1 enzyme encoded by the blaNDM-1 gene hydrolyzes β-lactam antibiotics, allowing the bacteria to escape the action of antibiotics. Although the biological functions and structural features of NDM-1 have been proposed according to results from functional and structural investigation of its homologues, the precise molecular characteristics and mechanism of action of NDM-1 have not been clarified. Here, we report the three-dimensional structure of NDM-1 with two catalytic zinc ions in its active site. Biological and mass spectroscopy results revealed that D-captopril can effectively inhibit the enzymatic activity of NDM-1 by binding to its active site with high binding affinity. The unique features concerning the primary sequence and structural conformation of the active site distinguish NDM-1 from other reported metallo-β-lactamases (MBLs) and implicate its role in wide spectrum drug resistance. We also discuss the molecular mechanism of NDM-1 action and its essential role in the pandemic of drug-resistant NDM-1 bacteria. Our results will provide helpful information for future drug discovery targeting drug resistance caused by NDM-1 and related metallo-β-lactamases.
Amino Acid Sequence
;
Anti-Bacterial Agents
;
metabolism
;
Binding Sites
;
Captopril
;
chemistry
;
pharmacology
;
Catalytic Domain
;
Crystallography, X-Ray
;
Drug Resistance, Bacterial
;
Enterobacteriaceae
;
enzymology
;
Molecular Sequence Data
;
Sequence Alignment
;
Sequence Homology, Amino Acid
;
beta-Lactamases
;
chemistry
;
metabolism

Result Analysis
Print
Save
E-mail